Why the study?
Does an initial strategy of PTCA compared to medical management increase health service costs in patients with angina and coronary artery disease?
Population
1018 patients with arteriographically proven coronary artery disease and angina
Comparison
Initial strategy of percutaneous transluminal… vs Continued medical management
Design
RCT, Randomized (504 to PTCA and 514 to continued medical management)
Follow-up
3 years
Authors
Loading...
PTCA increases 3-year costs versus medical management; challenges initial invasive strategy in stable angina while extending cost data for revascularization trials.
Does an initial strategy of PTCA compared to medical management increase health service costs in patients with angina and coronary artery disease?
An initial strategy of PTCA for angina is significantly more expensive than medical management over 3 years, costing 74% more.
Mark Sculpher (2002) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: